Chief Commercial Officer
Chris leads the EVERSANA and Evoke partnership in the launch and commercialization of GIMOTI®, a treatment for adult patients with diabetic gastroparesis. He brings more than 30 years of experience in building and executing on commercial strategies for pharmaceutical companies and has held roles across commercial strategy sales, marketing and operations. He has spent most of his career in executive-level roles at leading pharmaceutical and life sciences companies. In his current role, he leads the commercialization efforts for GIMOTI®, which include driving strategic decision-making and execution across marketing, sales, market access and commercial operations, among other responsibilities.
Chris holds a bachelor’s degree in biology from Virginia Tech.